What the research found
An analysis of nearly 17,100 UK Biobank participants tracked their physical activity via wearable devices and estimated their aerobic fitness (VO2 max) through cycling tests. Over 7.8 years, researchers correlated these measures against recorded cardiovascular events—heart attacks, strokes, atrial fibrillation, and heart failure.
The key finding: meeting current guidelines (150 min/week of moderate-to-vigorous activity) was associated with only modest 8–9% risk reduction. To achieve what the researchers called "substantial protection" (>30% risk reduction), participants needed roughly 560–610 minutes per week—about four times the standard recommendation. Notably, less-fit individuals required approximately 30–50 extra minutes weekly compared to highly fit people to reach equivalent risk reductions.
Why it matters for you
If you're tracking cardiovascular biomarkers (resting heart rate, blood pressure) and using VO2 max as a fitness metric, this suggests your baseline fitness level directly influences how much volume you actually need to drive meaningful heart-health gains. Someone starting with poor cardiorespiratory fitness faces a steeper dose requirement than an already-fit person.
The practical implication: the 150-min guideline may be a floor, not a ceiling. If you're aiming to substantially lower cardiovascular event risk rather than meeting a minimum standard, expect to build toward 8–10 hours of moderate-vigorous work per week. For context, that's closer to endurance-training volumes than casual exercise. This aligns with what many performance-focused users already do, but it formalizes the dose–response relationship.
The finding also underscores why tracking VO2 max matters: it flags your individual "cost" for cardiovascular adaptation. Lower baseline fitness = greater need for training stimulus to unlock equivalent protection.
Caveats
- Observational study: cannot prove exercise caused the risk reduction; healthier, more motivated people may both exercise more and have fewer events for other reasons
- Estimated VO2 max: derived from a cycling test, not direct measurement (gas analysis), introducing some measurement error
- Selection bias: UK Biobank participants skew healthier and fitter than the general population; findings may not generalise to sedentary or unwell groups
- Incomplete exposure data: wearable tracking captured activity volume but not sedentary time or low-intensity movement, both potentially relevant to cardiovascular health
- Narrow demographics: 96% white, average age 57; limited diversity in sex and ethnicity limits applicability
- Follow-up period: 7.8 years is relatively short; longer-term outcomes unknown